Looking to update its existing set of endorsement guidelines for businesses, the FTC is proposing to increase its enforcement of fake reviews and other forms of misleading advertising according to this recent article from Forbes.
In a combination of moves, the U.S. Senate has not only broken the partisan deadlock at the FTC by approving the nomination of Alvaro M. Bodoya, but has also seen its commerce committee push forward a bill that would restore the FTC's consumer refund power.
The U.S. Senate has moved ever closer to approving nominees to both the FTC and FCC which would break the current partisan deadlocks in both agencies. This is major news as these nominations could shift the regulatory direction of both commissions moving forward. Learn more in this article from the Washington Post.
The FDA and FTC continue their crack down on COVID-19 related product claims. According to an article from The National Law Review, these two regulatory bodies have now jointly issued warning letters regarding such claims to multiple CBD companies.
As we move toward the end of the first quarter of 2022, the FTC is not waning in its enforcement when it comes to misleading COVID-19 claims. In this recent article from Winston & Strawn, the commission's focus in this area is noted and the need for direct sales companies to implement systems for identifying misleading claims is emphasized.
Commissioner Christine Wilson of the Federal Trade Commission (FTC) recently criticized the FTC Chair's current agenda during an ABA Fall Forum speech. She spoke her mind regarding the commission's current course of action and predicted it would fall short of its goals while identifying four critical mistakes.
By successfully utilizing Section 19 of the FTC Act, the Federal Trade Commission has found a new avenue to restitution after Section 13(b) was vacated by the Fifth Circuit. An article from JD Supra details this important development.